Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.30 USD
+0.21 (19.27%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Apyx Medical Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -18.85 | -23.28 | -15.20 | -11.91 | -19.71 |
Depreciation/Amortization & Depletion | 0.69 | 0.89 | 0.90 | 0.89 | 0.75 |
Net Change from Assets/Liabilities | 5.54 | -5.22 | -1.84 | -10.25 | -3.32 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.37 | 7.33 | 5.69 | 5.21 | 3.80 |
Net Cash From Operating Activities | -5.25 | -20.28 | -10.45 | -16.07 | -18.48 |
Property & Equipment | 6.73 | -1.01 | -0.72 | -0.58 | -1.30 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 61.84 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 6.73 | -1.01 | -0.72 | -0.58 | 60.54 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.09 | 0.37 | 0.07 | 0.15 | 0.21 |
Issuance (Repayment) of Debt | 43.44 | -0.15 | -0.24 | -0.37 | -0.06 |
Increase (Decrease) Short-Term Debt | 2.63 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -13.99 | 0.00 | 0.20 | 0.15 | 0.00 |
Net Cash from Financing Activities | 32.17 | 0.22 | 0.02 | -0.07 | 0.15 |
Effect of Exchange Rate Changes | -0.19 | 0.40 | 0.10 | -0.18 | 0.00 |
Net Change In Cash & Equivalents | 33.46 | -20.68 | -11.05 | -16.90 | 42.22 |
Cash at Beginning of Period | 10.19 | 30.87 | 41.92 | 58.81 | 16.60 |
Cash at End of Period | 43.65 | 10.19 | 30.87 | 41.92 | 58.81 |
Diluted Net EPS | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 |
Fiscal Year End for Apyx Medical Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -14.18 | -7.59 | -18.85 | -9.23 | -4.55 |
Depreciation/Amortization & Depletion | 0.31 | 0.16 | 0.69 | 0.54 | 0.35 |
Net Change from Assets/Liabilities | 0.39 | -0.31 | 5.54 | 3.29 | -3.16 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.81 | 1.41 | 7.37 | 2.36 | 0.62 |
Net Cash From Operating Activities | -10.67 | -6.34 | -5.25 | -3.04 | -6.73 |
Property & Equipment | -0.32 | -0.04 | 6.73 | 6.83 | 7.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.32 | -0.04 | 6.73 | 6.83 | 7.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.09 | 0.67 | 0.64 |
Issuance (Repayment) of Debt | -0.01 | -0.01 | 43.44 | 9.26 | -0.02 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 2.63 | 0.00 | 9.29 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -13.99 | -1.61 | -1.75 |
Net Cash from Financing Activities | -0.01 | -0.01 | 32.17 | 8.32 | 8.16 |
Effect of Exchange Rate Changes | 0.03 | 0.01 | -0.19 | -0.17 | -0.14 |
Net Change In Cash & Equivalents | -10.97 | -6.37 | 33.46 | 11.94 | 8.29 |
Cash at Beginning of Period | 43.65 | 43.65 | 10.19 | 10.19 | 10.19 |
Cash at End of Period | 32.68 | 37.28 | 43.65 | 22.13 | 18.48 |
Diluted Net EPS | -0.19 | -0.22 | -0.28 | -0.13 | -0.03 |